Department of Psychiatry, TEACCH Autism Program, University of North Carolina at Chapel Hill.
Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill.
J Clin Child Adolesc Psychol. 2021 Jul-Aug;50(4):517-524. doi: 10.1080/15374416.2020.1833735. Epub 2020 Nov 19.
The heterogeneous symptom presentation of autism spectrum disorder (ASD) requires clinicians to consider each child's unique constellation of symptoms and tailor intervention accordingly. Treatment moderators, though necessary to guide evidence-based treatment decisions, are significantly under-studied. This brief report aims to expand on previous literature by providing an overview of characteristics which may influence treatment outcome and specifying future directions to build on this preliminary evidence base.
A subset of treatment modalities was identified from the National Clearinghouse on Autism Evidence and Practice Review Team's most recent report including discrete trial early intensive behaviorally based treatment, social skills training, and cognitive behavioral interventions. Within these treatment modalities, individual interventions with significant support were specifically discussed. Due to the lack of research on treatment moderators, a discussion of significant predictors of treatment outcome is also included.
Preliminary evidence suggests that overall, treatment intensity, duration, and parent involvement are the most consistently identified predictors (and in some studies, moderators) of treatment outcome; sessions which occur more frequently, continue for longer periods of time, and include parent training or coaching may yield the best outcomes. Other characteristics, including age and IQ, have been widely debated, with differing results found across treatment modalities.
The sparsity of research demonstrates a clear need for continued research on moderators to guide clinical judgment. Future studies that recruit larger samples targeting specific ASD symptoms at specific ages may be more adequately powered to detect these moderating effects.
自闭症谱系障碍(ASD)的症状表现存在异质性,这要求临床医生考虑每个孩子独特的症状组合,并相应地调整干预措施。尽管治疗调节剂对于指导基于证据的治疗决策是必要的,但它们的研究却明显不足。本简要报告旨在通过概述可能影响治疗结果的特征,并指明进一步构建这一初步证据基础的未来方向,来扩展先前的文献。
从国家自闭症证据与实践审查小组的最新报告中确定了一组治疗方式,包括离散试验早期密集行为基础治疗、社交技能训练和认知行为干预。在这些治疗方式中,特别讨论了具有显著支持的个别干预措施。由于缺乏治疗调节剂的研究,还讨论了治疗结果的显著预测因素。
初步证据表明,总体而言,治疗强度、持续时间和家长参与是治疗结果最一致的预测因素(在某些研究中也是调节剂);频率更高、持续时间更长且包括家长培训或指导的治疗方案可能会产生最佳结果。其他特征,包括年龄和智商,存在广泛争议,不同的治疗方式得出了不同的结果。
研究的匮乏清楚地表明,需要继续研究调节剂,以指导临床判断。未来的研究,如果能招募更多的特定年龄的特定 ASD 症状的样本,可能会更有能力检测到这些调节效应。